New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on: December 22,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on:December 22,2023

Exploring the role of artificial intelligence in early cancer detection

by Kathryn Ryan,Mary Ann Liebert, IncCredit: AI-generated imageTwo new review articles inAI in Precision Oncologyexplore the role of artificial intelligence (AI) in early cancer dete

Updated on: April 30,2024

Exploring the role of artificial intelligence in early cancer detection

by Kathryn Ryan,Mary Ann Liebert, IncCredit: AI-generated imageTwo new review articles inAI in Precision Oncologyexplore the role of artificial intelligence (AI) in early cancer dete

Updated on:April 30,2024

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut

Updated on: December 18,2023

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut

Updated on:December 18,2023

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (

Updated on: January 30,2024

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (

Updated on:January 30,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on: January 26,2024

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on:January 26,2024

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on: December 28,2023

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on:December 28,2023

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on: December 18,2023

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on:December 18,2023

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may

Updated on: December 25,2023

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may

Updated on:December 25,2023

Preventing 'identity theft' in prostate cancer cells re-sensitizes them to therapy

byUT Southwestern Medical CenterJAK–STAT signaling is required for Enz resistance in TP53/RB1-deficient mCRPC.a, Heat map representing the significantly changed signaling pathways in LNCaP

Updated on: December 22,2023

Preventing 'identity theft' in prostate cancer cells re-sensitizes them to therapy

byUT Southwestern Medical CenterJAK–STAT signaling is required for Enz resistance in TP53/RB1-deficient mCRPC.a, Heat map representing the significantly changed signaling pathways in LNCaP

Updated on:December 22,2023

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121

Updated on: May 16,2024

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121

Updated on:May 16,2024

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

Updated on: December 18,2023

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

Updated on:December 18,2023

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Updated on: February 20,2024

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Updated on:February 20,2024